Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GIK after pediatric cardiopulmonary bypass heart surgery
IRCT20190109042306N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2015
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-blind trial of glucose, human insulin and Potassium in Cardiovascular Malformation (CVM) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Arrhythmia, Need for shock and injection of inotrop and 4 more. Started Mar 2015; status: completed.
02
Drugs
glucosehuman insulinPotassium
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on IRCT20190109042306N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190109042306N1.